FDA conditionally approves second cohort of Carmat’s artificial heart study
Carmat has secured conditional approval from the FDA to commence the second cohort of its EFS in the US with the Aeson artificial heart. The post FDA conditionally approves second cohort of Carmat’s artificial heart study appeared first on Medical Device Network.
Carmat has secured conditional approval from the FDA to commence the second cohort of its EFS in the US with the Aeson artificial heart.
The post FDA conditionally approves second cohort of Carmat’s artificial heart study appeared first on Medical Device Network.
